HEALTH● ELEVATED2h ago · Sep 14, 2026, 5:03 AM
US push to cut drug prices could mean longer waits for European patients
EuroNews [en] · global
Europe’s patients could face longer waits for some new medicines as US efforts to drive down drug prices risk encouraging pharmaceutical companies to delay launches in lower-price markets, according to a new modelling study.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH45m agoNARD backs LASUTH doctors’ strike, urges Lagos govt to resolve disputePremium TimesHEALTH49m agoSuicide rates are gradually falling in the EU, but men are still more drastically affected than womenEuroNews [en]HEALTH2h agoHuge gaps in sanitary pad absorption speeds, over half poorly labelled: surveySouth China Morning PostHEALTH2h agoUnqualified practitioners found treating patients, prescribing allopathic medicines in HyderabadThe Hindu